THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

James George to Glucocorticoids

This is a "connection" page, showing publications James George has written about Glucocorticoids.
Connection Strength

0.887
  1. Immune thrombocytopenic purpura--let the treatment fit the patient. N Engl J Med. 2003 Aug 28; 349(9):903-5.
    View in: PubMed
    Score: 0.211
  2. Treatment options for chronic idiopathic (immune) thrombocytopenic purpura. Semin Hematol. 2000 Jan; 37(1 Suppl 1):31-4.
    View in: PubMed
    Score: 0.164
  3. Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2019 07 04; 381(1):92-94.
    View in: PubMed
    Score: 0.158
  4. Management of immune thrombocytopenia--something old, something new. N Engl J Med. 2010 Nov 11; 363(20):1959-61.
    View in: PubMed
    Score: 0.087
  5. Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost. 2006 Aug; 4(8):1664-72.
    View in: PubMed
    Score: 0.065
  6. Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher. 2006 Apr; 21(1):49-56.
    View in: PubMed
    Score: 0.063
  7. Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol. 2003 Nov; 74(3):161-9.
    View in: PubMed
    Score: 0.053
  8. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following treatment with deoxycoformycin in a patient with cutaneous T-cell lymphoma (Sezary syndrome): A case report. Am J Hematol. 1999 Aug; 61(4):268-70.
    View in: PubMed
    Score: 0.040
  9. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996 Jul 01; 88(1):3-40.
    View in: PubMed
    Score: 0.032
  10. The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology. J Pediatr Hematol Oncol. 2004 Feb; 26(2):146-51.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES